HPV and Cervical Cancer Screening Peter Valenzuela, MD, MBA, FAAFP Assistant Dean for Clinical Affairs Assistant Professor/Dept. of Family Medicine
Objectives Discuss key aspects of HPV including: Types Transmission Course Detection Vaccine Describe cervical cancer screening guidelines Provide an introduction to colposcopy using cervical images
Background Human papillomavirus (HPV) is the most common sexually transmitted infection in the U.S. Over half of sexually active men and women are infected with HPV at some point in their lives 6.2 million people in the U.S. become infected annually
Economic Impact Approximately $3.5 billion spent on cervical HPV-related disease in the U.S. annually  This image is Figure 13 at:  http://www.merckmedicus.com/pp/us/hcp/diseasemodules/hpvd/epidemiology.jsp
Types There are over 100 different types of HPV Over 40 types infect mucosal surfaces of the ano-genital area High risk  (cancer-associated)- 16,18 ,31,33,35,39,45,51,52,56,58,59,68,82 Low risk  (non-oncogenic)-  6,11 ,40,42,43,44,54,61,72,73,81
Types High Risk  HPV 16 most common (found in almost half of all cervical CA) HPV 18 accounts for 10%-12% of cervical CA Low Risk HPV 6 & 11 most commonly found in genital warts
Transmission Usually transmitted through direct skin-to-skin Can occur from mother to baby in delivery Detected on inanimate objects, but transmission via this route is unknown This image is Figure 14 at:  http://www.merckmedicus.com/pp/us/hcp/diseasemodules/hpvd/epidemiology.jsp
Risk Factors for HPV Infection Young age (less than 25 years old) Increasing number of sex partners Early age at first intercourse (16 years old or younger) Male partner has (or has had) multiple sex partners
Course Typical duration of new infection is 8 months  70% of women become HPV negative within 1 year 91% become HPV negative within 2 years 10% of women infected with HPV will develop persistent HPV infections This image is Figure 19 at:  http://www.merckmedicus.com/pp/us/hcp/diseasemodules/hpvd/natural-history.jsp
Detection HPV DNA test (Hybrid Capture II) Can be analyzed from the residual fluid of a liquid-based cytology specimen Detects high risk HPV types, but does not identify individual type Indications for use Routine adjunct to Pap in women 30 and over Management of ASCUS
Prevention of HPV Quadrivalent HPV vaccine (Gardasil) Protects against HPV 6,11,16,18 3 IM injections over six-month period ($360 for series) Indicated in females 9-26 years old Ideally before onset of sexual activity
Cervical Cancer Screening This is table 12 at:  http://www.merckmedicus.com/pp/us/hcp/diseasemodules/hpvd/screening.jsp  
Cervical Dysplasia Classification Bethesda System- developed by the CDC and NIH to standardize method CIN Grading System CIN III HGSIL Carcinoma In Situ CIN II HGSIL CIN I LGSIL Atypia ASCUS CIN GRADING BETHESDA
Management of an Abnormal Pap This is the first image on page 22 of the CDC brochure and may be found at:  http://www.cdc.gov/std/HPV/common-infection/CDC_HPV_ClinicianBro_LR.pdf
Management of an Abnormal Pap This is the second image on page22 of the CDC brochure and may be found at:  http://www.cdc.gov/std/HPV/common-infection/CDC_HPV_ClinicianBro_LR.pdf
Colposcopy This image can be found at:  http://medicalimages.allrefer.com/large/colposcopy-directed-biopsy.jpg
Colposcopy  Ectopy Nabothian Cyst This image can be found at:  http://www.asccp.org/edu/practice/cervix/colposcopy/benign.shtml This image can be found at:  http:// www.asccp.org/edu/practice/cervix/colposcopy/benign.shtml
Colposcopy Leukoplakia This image can be found at:  http://www.asccp.org/edu/practice/cervix/colposcopy/benign.shtml
Colposcopy Punctation This is image 7.3 at:  http://screening.iarc.fr/colpochap.php?lang=1&chap=7.php
Colposcopy Mosaicism CIN I This is image 7.16 at:  http://screening.iarc.fr/colpochap.php?lang=1&chap=7.php
Colposcopy CIN II CIN III This is image 7.19 at:  http://screening.iarc.fr/colpochap.php?lang=1&chap=7.php This is image 7.23 at:  http://screening.iarc.fr/colpochap.php?lang=1&chap=7.php
Colposcopy Strawberry Cervix  Common indicator of cervicitis Trichomoniasis is usually the culprit  This image can be found at:  http://www.asccp.org/edu/practice/cervix/colposcopy/benign.shtml
Summary Discuss key aspects of HPV including: Types Transmission Course Detection Vaccine Describe cervical cancer screening guidelines Provide an introduction to colposcopy using cervical images
References Centers for Disease control and Prevention  http://www.cdc.gov/std/hpv/hpv-clinicians-brochure.htm American Society for Colposcopy and Cervical Pathology  http:// www.asccp.org/edu/practice/cervix.shtml American College of Obstetricians and Gynecologists  http:// www.acog.org /
References Pfenninger and Fowler’s Procedures for Primary Care, 2 nd  Ed. 2003 Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginner’s Mannual. Edited by Edited by J.W. Sellors and R. Sankaranarayanan   HPV Disease  www.merckmedicus Women’s Health Channel  www.womenshealthchannel.com

HPV and Cervical Cancer Screening

  • 1.
    HPV and CervicalCancer Screening Peter Valenzuela, MD, MBA, FAAFP Assistant Dean for Clinical Affairs Assistant Professor/Dept. of Family Medicine
  • 2.
    Objectives Discuss keyaspects of HPV including: Types Transmission Course Detection Vaccine Describe cervical cancer screening guidelines Provide an introduction to colposcopy using cervical images
  • 3.
    Background Human papillomavirus(HPV) is the most common sexually transmitted infection in the U.S. Over half of sexually active men and women are infected with HPV at some point in their lives 6.2 million people in the U.S. become infected annually
  • 4.
    Economic Impact Approximately$3.5 billion spent on cervical HPV-related disease in the U.S. annually This image is Figure 13 at: http://www.merckmedicus.com/pp/us/hcp/diseasemodules/hpvd/epidemiology.jsp
  • 5.
    Types There areover 100 different types of HPV Over 40 types infect mucosal surfaces of the ano-genital area High risk (cancer-associated)- 16,18 ,31,33,35,39,45,51,52,56,58,59,68,82 Low risk (non-oncogenic)- 6,11 ,40,42,43,44,54,61,72,73,81
  • 6.
    Types High Risk HPV 16 most common (found in almost half of all cervical CA) HPV 18 accounts for 10%-12% of cervical CA Low Risk HPV 6 & 11 most commonly found in genital warts
  • 7.
    Transmission Usually transmittedthrough direct skin-to-skin Can occur from mother to baby in delivery Detected on inanimate objects, but transmission via this route is unknown This image is Figure 14 at: http://www.merckmedicus.com/pp/us/hcp/diseasemodules/hpvd/epidemiology.jsp
  • 8.
    Risk Factors forHPV Infection Young age (less than 25 years old) Increasing number of sex partners Early age at first intercourse (16 years old or younger) Male partner has (or has had) multiple sex partners
  • 9.
    Course Typical durationof new infection is 8 months 70% of women become HPV negative within 1 year 91% become HPV negative within 2 years 10% of women infected with HPV will develop persistent HPV infections This image is Figure 19 at: http://www.merckmedicus.com/pp/us/hcp/diseasemodules/hpvd/natural-history.jsp
  • 10.
    Detection HPV DNAtest (Hybrid Capture II) Can be analyzed from the residual fluid of a liquid-based cytology specimen Detects high risk HPV types, but does not identify individual type Indications for use Routine adjunct to Pap in women 30 and over Management of ASCUS
  • 11.
    Prevention of HPVQuadrivalent HPV vaccine (Gardasil) Protects against HPV 6,11,16,18 3 IM injections over six-month period ($360 for series) Indicated in females 9-26 years old Ideally before onset of sexual activity
  • 12.
    Cervical Cancer ScreeningThis is table 12 at: http://www.merckmedicus.com/pp/us/hcp/diseasemodules/hpvd/screening.jsp  
  • 13.
    Cervical Dysplasia ClassificationBethesda System- developed by the CDC and NIH to standardize method CIN Grading System CIN III HGSIL Carcinoma In Situ CIN II HGSIL CIN I LGSIL Atypia ASCUS CIN GRADING BETHESDA
  • 14.
    Management of anAbnormal Pap This is the first image on page 22 of the CDC brochure and may be found at: http://www.cdc.gov/std/HPV/common-infection/CDC_HPV_ClinicianBro_LR.pdf
  • 15.
    Management of anAbnormal Pap This is the second image on page22 of the CDC brochure and may be found at: http://www.cdc.gov/std/HPV/common-infection/CDC_HPV_ClinicianBro_LR.pdf
  • 16.
    Colposcopy This imagecan be found at: http://medicalimages.allrefer.com/large/colposcopy-directed-biopsy.jpg
  • 17.
    Colposcopy EctopyNabothian Cyst This image can be found at: http://www.asccp.org/edu/practice/cervix/colposcopy/benign.shtml This image can be found at: http:// www.asccp.org/edu/practice/cervix/colposcopy/benign.shtml
  • 18.
    Colposcopy Leukoplakia Thisimage can be found at: http://www.asccp.org/edu/practice/cervix/colposcopy/benign.shtml
  • 19.
    Colposcopy Punctation Thisis image 7.3 at: http://screening.iarc.fr/colpochap.php?lang=1&chap=7.php
  • 20.
    Colposcopy Mosaicism CINI This is image 7.16 at: http://screening.iarc.fr/colpochap.php?lang=1&chap=7.php
  • 21.
    Colposcopy CIN IICIN III This is image 7.19 at: http://screening.iarc.fr/colpochap.php?lang=1&chap=7.php This is image 7.23 at: http://screening.iarc.fr/colpochap.php?lang=1&chap=7.php
  • 22.
    Colposcopy Strawberry Cervix Common indicator of cervicitis Trichomoniasis is usually the culprit This image can be found at: http://www.asccp.org/edu/practice/cervix/colposcopy/benign.shtml
  • 23.
    Summary Discuss keyaspects of HPV including: Types Transmission Course Detection Vaccine Describe cervical cancer screening guidelines Provide an introduction to colposcopy using cervical images
  • 24.
    References Centers forDisease control and Prevention http://www.cdc.gov/std/hpv/hpv-clinicians-brochure.htm American Society for Colposcopy and Cervical Pathology http:// www.asccp.org/edu/practice/cervix.shtml American College of Obstetricians and Gynecologists http:// www.acog.org /
  • 25.
    References Pfenninger andFowler’s Procedures for Primary Care, 2 nd Ed. 2003 Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginner’s Mannual. Edited by Edited by J.W. Sellors and R. Sankaranarayanan HPV Disease www.merckmedicus Women’s Health Channel www.womenshealthchannel.com